Other OTC Pharmaceuticals - Armenia

  • Armenia
  • In Armenia, the revenue generated in the Other OTC Pharmaceuticals market amounted to US$3.75m in 2024.
  • It is projected that this market will experience an annual growth rate of 2.39% (CAGR 2024-2029).
  • When compared globally, the in the United States leads in terms of revenue, generating US$7,171.00m in 2024.
  • In relation to the total population, per person revenues amounted to US$1.35 in 2024.
  • Armenia's Other OTC Pharmaceuticals market is witnessing a surge in demand for traditional herbal remedies.

Key regions: United States, Brazil, Europe, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Armenia is experiencing significant growth and development.

Customer preferences:
Armenian consumers have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors, including the convenience and accessibility of these products. OTC medications are readily available in pharmacies and supermarkets without the need for a prescription, allowing consumers to easily purchase them for self-medication. Additionally, the affordability of OTC pharmaceuticals compared to prescription drugs has also contributed to their popularity among consumers.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals market in Armenia is the increasing demand for products that address common health issues. This includes medications for pain relief, cough and cold, allergies, and digestive problems. As these health issues are prevalent among the population, there is a growing need for effective and accessible OTC pharmaceuticals to alleviate symptoms and provide relief. Another trend in the market is the rising popularity of natural and herbal remedies. Armenian consumers are becoming more conscious of their health and are seeking alternative options to traditional pharmaceutical products. This has led to an increase in the demand for OTC herbal and natural remedies, such as herbal teas, supplements, and essential oils.

Local special circumstances:
Armenia's healthcare system is undergoing significant reforms, which has had an impact on the OTC Pharmaceuticals market. The government has implemented measures to improve access to healthcare services and increase the affordability of medications. This has resulted in a more favorable environment for the OTC Pharmaceuticals market, as consumers have greater access to these products and are more likely to purchase them for self-medication. Furthermore, the growing tourism industry in Armenia has also contributed to the development of the OTC Pharmaceuticals market. Tourists visiting the country often seek OTC medications for common health issues, and the availability of these products in pharmacies and supermarkets caters to their needs.

Underlying macroeconomic factors:
Armenia's growing economy and increasing disposable income levels have played a significant role in the development of the Other OTC Pharmaceuticals market. As consumers have more purchasing power, they are able to afford OTC medications and are more likely to purchase them for self-medication. Additionally, the country's aging population has also contributed to the growth of the OTC Pharmaceuticals market. With a larger elderly population, there is a higher demand for OTC medications to address common health issues associated with aging, such as joint pain and digestive problems. In conclusion, the Other OTC Pharmaceuticals market in Armenia is experiencing growth and development due to customer preferences for convenient and affordable healthcare solutions. The increasing demand for products that address common health issues, as well as the rising popularity of natural and herbal remedies, are key trends in the market. Local special circumstances, such as healthcare reforms and the growing tourism industry, have also contributed to the market's development. Additionally, underlying macroeconomic factors, such as the country's growing economy and aging population, have played a role in the market's growth.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)